Automated low flow pump system for the treatment of refractory ascites: A multi-center safety and efficacy study

Bellot, Pablo; Welker, Martin-Walter; Soriano, German; von Schaewen, Markus; Appenrodt, Beate; Wiest, Reiner; Whittaker, Steven; Tzonev, Radin; Handshiev, Stoyan; Verslype, Chris; Moench, Christian; Zeuzem, Stefan; Sauerbruch, Tilman; Guarner, Carlos; Schott, Ekart; Johnson, Noel; Petrov, Assen; Katzarov, Krum; Nevens, Frederik; Zapater, Pedro; ... (2013). Automated low flow pump system for the treatment of refractory ascites: A multi-center safety and efficacy study. Journal of hepatology, 58(5), pp. 922-927. Elsevier 10.1016/j.jhep.2012.12.020

Text Automated low flow pump system for the treatment of.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (761kB)

BACKGROUND & AIMS:

Refractory ascites (RA) affects 10% of patients with advanced cirrhosis and ascites. Usual therapy includes large volume paracentesis, and in selected patients, a transjugular portosystemic shunt (TIPS). These therapies may be associated with increased morbidity: paracentesis may induce circulatory dysfunction and impair quality of life and TIPS may induce encephalopathy and is associated with increased mortality in patients with severe liver dysfunction. We present the results of a multicenter, non-randomized trial to assess the safety and efficacy of a new automated pump system for treatment of RA.

METHODS:

Forty patients at 9 centers (February 2010-June 2011) received an implanted pump for the automated removal of ascites from the peritoneal cavity into the bladder, from where it was eliminated through normal urination. Patients were followed-up for 6months. The primary study outcome was safety. Secondary outcomes included recurrence of tense ascites and pump performance.

RESULTS:

Surgical complications occurred early in the study and became less frequent. The pump system removed 90% of the ascites and significantly reduced the median number of large volume paracentesis per month [3.4 (range 1-6) vs. 0.2 (range 0-4); p <0.01]. Cirrhosis-related adverse events decreased along follow-up.

CONCLUSIONS:

The automated pump seems an efficacious tool to move out ascites from the peritoneal cavity to the bladder. Its safety is still moderate, but a broad use in different countries will improve the surgical technique as well as the medical surveillance. A prospective randomized clinical trial vs. large volume paracentesis is underway to confirm these preliminary results.

Interest & Impact

Downloads

15 since deposited on 16 Jun 2014
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item